Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Income from Continuing Operations (2010 - 2026)

Omnicell's (OMCL) quarterly Income from Continuing Operations came in at $24.3 million in Q2 2026, up 330.73% year-over-year from $5.6 million in Q2 2025, and up 113.85% quarter-over-quarter from $11.4 million in Q1 2026.

Analysis

Omnicell (OMCL) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Income from Continuing Operations for 17 consecutive years, with $24.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations rose 330.73% year-over-year to $24.3 million in Q2 2026; TTM through Jun 2026 was $39.1 million, a 69.28% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, down 83.62% from the prior year.
  • Income from Continuing Operations was $24.3 million for Q2 2026 at Omnicell, up from $11.4 million in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at $24.3 million in Q2 2026 and troughed at -$28.4 million in Q4 2022.
  • A 5-year average of $2.0 million and a median of $5.5 million in 2023 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations tumbled 303.23% in 2022 and surged 330.73% in 2026, its largest moves.
  • Over 5 years, Income from Continuing Operations stood at -$28.4 million in 2022, then soared by 49.41% to -$14.4 million in 2023, then soared by 210.21% to $15.8 million in 2024, then plunged by 112.79% to -$2.0 million in 2025, then surged by 1298.86% to $24.3 million in 2026.
  • The last three Income from Continuing Operations figures came in at $24.3 million (Q2 2026), $11.4 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 823.20 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 1.48 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 241.40 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -92.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 249.10 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 383.43 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 24.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.29 Mn
Mar 31, 2026 11.36 Mn
Dec 31, 2025 -2.03 Mn
Sep 30, 2025 5.46 Mn
Jun 30, 2025 5.64 Mn
Mar 31, 2025 -7.02 Mn
Dec 31, 2024 15.84 Mn
Sep 30, 2024 8.63 Mn
Jun 30, 2024 3.74 Mn
Mar 31, 2024 -15.63 Mn
Dec 31, 2023 -14.38 Mn
Sep 30, 2023 5.55 Mn
Jun 30, 2023 3.45 Mn
Mar 31, 2023 -14.98 Mn
Dec 31, 2022 -28.41 Mn
Sep 30, 2022 16.77 Mn
Jun 30, 2022 9.07 Mn
Mar 31, 2022 8.21 Mn
Dec 31, 2021 13.98 Mn
Sep 30, 2021 29.32 Mn